![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 28, 25457-25464, July 12, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Conversion of the normal membrane-bound prion
protein (PrP-sen) to its pathological isoform (PrP-res) is a key event
in the pathogenesis of transmissible spongiform encephalopathies.
Although the subcellular sites of conversion are poorly characterized, several lines of evidence have suggested the involvement of membrane lipid rafts in the conversion process. Here we report that copper stimulates the endocytosis of PrP-sen via a
caveolin-dependent pathway in both microglia and
neuroblastoma cells. We show that the polyene antibiotic filipin both
limits endocytosis of PrP-sen and dramatically reduces the amount of
membrane-bound PrP-sen. This reduction results from a rapid and massive
release of full matured PrP-sen into the culture medium. Finally, we
demonstrate that filipin is a potent inhibitor of PrP-res formation
into chronically infected neuroblastoma cells. Our results reinforce
the role of rafts in PrP trafficking and raise the possibility that the
release of PrP-sen from the plasma membrane decreases the amount of
available substrate PrP-sen at the conversion sites.
Filipin Prevents Pathological Prion Protein
Accumulation by Reducing Endocytosis and Inducing Cellular PrP
Release*
,
Institut de Pharmacologie Moléculaire
et Cellulaire, Unité Mixte de Recherche 6097, Centre National de
la Recherche Scientifique, 660 Route des Lucioles, 06560 Valbonne,
France, the § Institut de Génétique Humaine,
Centre National de la Recherche Scientifique, 34396 Montpellier,
France, and the ¶ Service de Pharmacologie et d'Immunologie,
Commisariat à l'Energie Atomique,
91191 Gif-sur-Yvette, cedex, France
*
This work was supported in part by French government grants
from the "Action Concertée Incitive" Jeunes Chercheurs (2000) and by the "Groupement d'Intèrêt Scientifique"
Infections à Prions (2001).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: IPMC, CNRS, 660 Route des Lucioles, 06560 Valbonne, France. Tel.:
334-93-95-77-67; Fax: 334-93-95-77-08; E-mail:
chabry@ipmc.cnrs.fr.
This article has been cited by other articles:
![]() |
R. Kumar, D. McClain, R. Young, and G. A. Carlson Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells J. Gen. Virol., June 1, 2008; 89(6): 1525 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani Physiology of the Prion Protein Physiol Rev, April 1, 2008; 88(2): 673 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Campana, A. Caputo, D. Sarnataro, S. Paladino, S. Tivodar, and C. Zurzolo Characterization of the Properties and Trafficking of an Anchorless Form of the Prion Protein J. Biol. Chem., August 3, 2007; 282(31): 22747 - 22756. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kleine-Vehn, P. Dhonukshe, R. Swarup, M. Bennett, and J. Friml Subcellular Trafficking of the Arabidopsis Auxin Influx Carrier AUX1 Uses a Novel Pathway Distinct from PIN1 PLANT CELL, November 1, 2006; 18(11): 3171 - 3181. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Campana, D. Sarnataro, C. Fasano, P. Casanova, S. Paladino, and C. Zurzolo Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum J. Cell Sci., February 1, 2006; 119(3): 433 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Taylor, N. T. Watt, W. S. S. Perera, and N. M. Hooper Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis J. Cell Sci., November 1, 2005; 118(21): 5141 - 5153. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bate, S. Reid, and A. Williams Phospholipase A2 Inhibitors or Platelet-activating Factor Antagonists Prevent Prion Replication J. Biol. Chem., August 27, 2004; 279(35): 36405 - 36411. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bate, M. Salmona, L. Diomede, and A. Williams Squalestatin Cures Prion-infected Neurons and Protects Against Prion Neurotoxicity J. Biol. Chem., April 9, 2004; 279(15): 14983 - 14990. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Parkin, N. T. Watt, A. J. Turner, and N. M. Hooper Dual Mechanisms for Shedding of the Cellular Prion Protein J. Biol. Chem., March 19, 2004; 279(12): 11170 - 11178. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Daude, M. Marella, and J. Chabry Specific inhibition of pathological prion protein accumulation by small interfering RNAs J. Cell Sci., July 1, 2003; 116(13): 2775 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A Harris Trafficking, turnover and membrane topology of PrP: Protein function in prion disease Br. Med. Bull., June 1, 2003; 66(1): 71 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dormont Approaches to prophylaxis and therapy: An investigation into prion disease diversity Br. Med. Bull., June 1, 2003; 66(1): 281 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nunziante, S. Gilch, and H. M. Schatzl Essential Role of the Prion Protein N Terminus in Subcellular Trafficking and Half-life of Cellular Prion Protein J. Biol. Chem., January 31, 2003; 278(6): 3726 - 3734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Sukumaran, M. J. Quon, and N. V. Prasadarao Escherichia coli K1 Internalization via Caveolae Requires Caveolin-1 and Protein Kinase Calpha Interaction in Human Brain Microvascular Endothelial Cells J. Biol. Chem., December 20, 2002; 277(52): 50716 - 50724. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |